Events in 2016

Date & Time

8th December 2016 (Thu) 2:00pm - 4:00pm

Venue

Meeting Room 1, 1/F, InnoCentre, 72 Tat Chee Avenue, Kowloon Tong, Kowloon.

Intro

For years, Cytelligen and Cytointelligen have been working closely with doctors and research professionals in U.S. and China on clinical and translational technologies relating to Enumeration of circulating tumor cells (CTCs). Circulating tumor cells (CTCs) are tumor cells released from the primary tumor mass into peripheral blood. Following circulating in blood, some of CTCs are apoptotic, and some of those survived CTCs may reach a target organ and attach to the endothelial cell. After invading the endothelium, a secondary tumor mass will develop. The similar process is shared by cancer relapse. Cytelligen has developed an unique integrated platform of subtraction enrichment (SE) and immunostaining-FISH (iFISH) to efficiently detect circulating rare cells, including CTC shed from various epithelial solid tumors, circulating endothelial cell (CEC), and stem cell, etc.. The SE-iFISH technology is widely used for its uniqueness and precision on detecting tumor cells as well as related translational researches which has granted international recognition by international journal such as Science (Science 2013,341:415).
 
This discussion will provide an understanding of the SE-iFISH technology by Cytelligen and Cytointelligen and the various application of the SE-iFISH technology on cancer diagnostics, which might cover,
 
1. introduction to the subtraction enrichment (SE) and immunostaining-FISH (iFISH)  SE-iFISH technology
2. Explore the Cytelligen Integrated Platform to Isolate, Detect and Analyze CTC
3. Discussion with fellows in Hong Kong
 
We aim to provide participants with understanding of the SE-iFISH technology and opportunity for potential collaboration.

Objective

To explore and discuss the possibility in terms of clinical and biomedical research application of detecting circulating tumor cells via the unique SE-iFISH platform in Hong Kong.

About Cytelligen & Cytointelligen

Cytelligen is located in San Diego, California, USA. Cytelligen's subsidiary facility - Cytointelligen is in China Medical City, Taizhou, Jiangsu, China.

Cytelligen and Cytointelligen, the inventor of SE-iFISH technology, hold patents and trade marsk relative to enrichment and identification of circulating tumor cells. This technology has been validated on over 3000 thousands clinical samples of various cancer patients.

Speakers

Dr. Peter Lin

Fee

Free of charge

Target Audience

- Investors

- Doctors

- Hong Kong Medial Lab representatives

- Product Managers

Languages

 

English/Mandarin

 

For enquiry, please contact:

Mr. Dhanat Sirimongkolkasem (Tony)

This email address is being protected from spambots. You need JavaScript enabled to view it.

Tel: 39022921

*Please bring along two business card to sign-in

 

Schedule (Subject to change without prior notice)

2:00 – 2:15 pm

Registration

2:15 – 3:00 pm

Presentation by Dr. Peter Lin

3:00 – 3:15 pm

Q&A

3:15 – 3:55 pm

Discussion

3:55 – 4:00 pm

Group photo taking

4:00 pm

End of Session

This Session is sponsored by Hong Kong Science and Technology Park Corporation

Registry NOW!

Required *

 

May 25 - 28, 2016

Hong Kong Biotechnology Organization (HKBIO) has co-organized with The Chinese Manufacturer's Association of Hong Kong (CMA) and Neuroscience Research Institute of Peking University on the second series Hong Kong Biotech Horizons event namely Ageing Brain in Health which constituted a three-and-a-half-day “12th international conference on brain energy metabolism”

As part of the Hong Kong Biotech Horizons series 2016, HKBIO organized and led the 12th International Conference on Brain Energy Metabolism, titled "Energy Metabolism and Neuron-Glia Interactions in Brain: from Molecular Mechanisms to Novel Therapeutic Approaches". Upholding the principal of creating an interdisciplinary platform comprised of scientific researchers, technology developers and entrepreneurs, designed to combine disciplines, resources, expertise, and techniques, the conference aimed towards preventions, diagnosis, as well as therapies in diverse aspects of brain energy metabolism.

The overall programme included two keynote lectures and nine symposia with twenty-nine of our invited speakers, over 12 countries and regions attended the ICBEM. The 1st Keynote lecturer is Prof. Ursula Sonnewald, from the Norwegian University of Science and Technology (Norway). And the 2nd Keynote lecturer is Prof. Vladimir Parpura from the University of Alabama Birmingham (United States).

The programme’s topics ranged from interactions of various substances of the brain, to regulations of brain metabolism through different mechanisms as well as solutions to effective treatments of metabolic disorders concerning the brain. Collectively, these topics were covered for neurological experts to work together on the extensive and competent world of professionals and researchers on the other.

We had 258 participants from over 20 countries and regions attended the ICBEM, including graduate students, postdoctoral researcher, professors, research scientists and research directors. Furthermore, the event was successfully live webcasted online during the conference period, and there were 240 people viewed the conference online.

We have received very positive feedback from the participants and compliments on the conference were abundant. Over 90% of the respondents agreed presentations were at the frontier of the field according to our survey result and over 85% of them expressed that conference was thought-provoking, stimulating, exciting and they looked forward to the next meeting in 2018.

April 6, 2016

The Seminar was organized by the Chinese Manufacture’s Association of Hong Kong. And associate by HKBIO. Our Council member, Prof Ken Yung had been invited to serve as the session speaker along with Dr Gong Chen (Professor of Pennsylvania State University) . The seminar had around 30 people attend, some of them are the senior business executive. The participants learnt about the latest research in stem cell, along with the abundant investment opportunities in this field.

March 5, 2016

HKBIO had been invited to be one of the exhibitor in the Career Expo 2016. The event had attracted 5,400 students, fresh graduates and job seekers.

HKBIO take this opportunity to introduce the Hong Kong Biotechnology sector to the public, and recruit more than 50 members in this event.

February 27, 2016

The first of IFHK’s Town and Gown Lecture Series was held in February 2016. The theme of this event is “ Life Sciences Entrepreneurship in Asia - What Works, What Doesn't and How to Improve It?”  It aims to bring together stakeholders across fields of life sciences and entrepreneurship to explore key issues in Asia. Prof. Albert Yu, Chairman of Hong Kong Biotechnology Organization has served as a speaker at this event and HKBIO had been invited to serve as the supporting organization too. HKBIO had always put in a lot of effort to develop the Hong Kong’s Biotech sector.

Free Joomla! template by Age Themes